Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 Provinces of Spain
| dc.contributor.author | Galceran, Jaume | |
| dc.contributor.author | Ameijide, Alberto | |
| dc.contributor.author | Jeghalef, Noura | |
| dc.contributor.author | Sánchez Gil, Antonia | |
| dc.contributor.author | Guevara, Marcela | |
| dc.contributor.author | Bigorra, Jàmnica | |
| dc.contributor.author | Gutiérrez, Pilar | |
| dc.contributor.author | Boone, An L.D. | |
| dc.contributor.author | Garrido, Montserrat | |
| dc.contributor.author | Álvarez, Xitama | |
| dc.contributor.author | Vizcaíno, Ana | |
| dc.contributor.author | Martín, Isabel | |
| dc.contributor.author | Onaindia, Amaia | |
| dc.contributor.author | Sanclemente, Silvia | |
| dc.contributor.author | Trallero, Jan | |
| dc.contributor.author | Sánchez Pérez, María José | |
| dc.contributor.author | Palacios Castaño, María Isabel | |
| dc.contributor.author | Clèries Soler, Ramon | |
| dc.contributor.author | Carulla, Marià | |
| dc.date.accessioned | 2026-10-21T13:53:16Z | |
| dc.date.available | 2026-10-21T13:53:16Z | |
| dc.date.issued | 2026-06-18 | |
| dc.date.updated | 2026-10-21T13:53:17Z | |
| dc.description.abstract | Background: Childhood cancer survivors have a higher risk of developing malignancies later in life compared with individuals of similar age in the general population. In Spain, population-based evidence on second malignant neoplasms (SMNs) is limited. This study aimed to estimate survival following childhood cancer diagnosis and to assess the risk of SMNs in Spain. Methods: This population-based registry study used data from 12 cancer registries within the Spanish Network of Cancer Registries (REDECAN). All malignancies of sites and non-malignant central nervous system (CNS) tumors diagnosed before age 15 were included. Age-standardized incidence rates (ASIRw) for 2015–2019 were calculated. Five- and 10-year age-adjusted observed survival rates for 1990–1999 and 2000–2009 were estimated. SMN risk was assessed using standardized incidence ratios (SIRs) and excess absolute risks (EARs). Results: The ASIRw for 2015–2019 was 181.3 per million child-years. Ten-year survival increased from 71.3% in 1990–1999 to 75.5% in 2000–2009. The overall risk of developing an SMN was significantly elevated (SIR = 5.67) at 20 years. Conclusions: Although survival for childhood cancer in Spain was around 75% in 2000–2009, childhood cancer survivors remain at substantially increased risk of SMNs for at least two decades. Efforts to reduce treatment-related toxicity while maintaining survival gains are essential. | |
| dc.format.extent | 21 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 771207 | |
| dc.identifier.issn | 2072-6694 | |
| dc.identifier.pmid | 42352523 | |
| dc.identifier.uri | https://hdl.handle.net/2445/232223 | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/cancers18121991 | |
| dc.relation.ispartof | Cancers, 2026, vol. 18, num.12 | |
| dc.relation.uri | https://doi.org/10.3390/cancers18121991 | |
| dc.rights | cc-by (c) Galceran J et al., 2026 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.classification | Malalts de càncer | |
| dc.subject.classification | Càncer en els infants | |
| dc.subject.other | Cancer patients | |
| dc.subject.other | Cancer in children | |
| dc.title | Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 Provinces of Spain | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1